CBX3 Accelerates the Malignant Progression of Glioblastoma Multiforme by Stabilizing EGFR Expression

Researchers reported the identification of CBX3 as a potential therapeutic target for glioblastoma multiforme (GBM) and found that, CBX3 was significantly upregulated in GBM and reduced patient survival.